Vir Biotechnology, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $2.7M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $62.5M |
| SG&A Expense | $21.7M |
| Operating Income | $-81.5M |
| Operating Margin | -3,009.5% |
| Interest Expense | — |
| Pretax Income | $-80.8M |
| Income Tax Expense | $-10.9M |
| Net Income | $-69.9M |
| Net Margin | -2,579.5% |
| EPS (Basic) | $-8.11 |
| EPS (Diluted) | $-8.11 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |